Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Otolaryngology | Immunology/Infectious Diseases
Disease Category: Allergies & Asthma

Trial Information

Ragweed Allergy Study

This study is to test the efficacy and safety of a sublingual tablet of ragweed allergen extract given for immunotherapy instead of a shot.

Patient Inclusion Critieria

• 18-50 years old with significant ragweed allergy for at least 2 years with or without asthma who received treatment for allergies during the previous ragweed season.
• Able to adhere to study procedures and schedule.

Patient Exclusion Critieria

• Subjects with significant year round allergies
• Immunotherapy (allergy shots) within the last five years.
• Moderate to severe asthma.
• Chronic urticaria or angioedema.

Nancy Canada, LVN, CCRC, Study Coordinator
Allergy Asthma Research Institute
333 Londonderry Drive, Suite #110
Waco, TX 76712
Phone: 254-751-1144, option 11

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.